Back to Authors

Emmanouilides, C.

A5042921233 | I111979921

Mayo Clinic

Northwestern University

Citations 2

Low incidence of treatment-related myelodysplastic syndrome (tMDS) and acute myelogenous leukemia (tAML) in patients with non-Hodgkin's lymphoma (NHL) treated with ibritumomab tiuxetan

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 6696-6696

10.1200/jco.2004.22.90140.6696

Yttrium 90 ibritumomab tiuxetan is safe and effective in older patients with relapsed or refractory NHL

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 6562-6562

10.1200/jco.2005.23.16_suppl.6562